Nina Mars
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nina Mars has a total of 445 co-authors. Here are the top co-authors by number of shared publications:
- Samuli Ripatti
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
26 shared publications Finn Gen
22 shared publicationsSamuli Ripatti
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Department of Public Health, University of Helsinki, Helsinki, Finland
12 shared publications- Aarno Palotie
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
10 shared publications Aarno Palotie
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Analytic and Translational Genetics Unit (ATGU), Department of Medicine, Department of Neurology and Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
9 shared publications- Tuomo Kiiskinen
Stanford University
9 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 7 (3) , 100633
Genetic architecture of 67 oral diseases and their links to systemic diseases
- 17 June 2026
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 7 (3) , 100633
Open AccessGenetic architecture of 67 oral diseases and their links to systemic diseases
- Open Access
- 11 June 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Association and risk prediction of 19 complex diseases with polygenic scores and socioeconomic status
Background: Differences in disease risk are linked to inherited genetic variation and social circumstances, but how these factors jointly relate to multiple diseases is not fully understood. This study investigates the independent and combined associations of genetic predisposition and socioeconomic status with common diseases. Methods: We analyzed data from 743,194 adults from three biobank studies in Finland and the United Kingdom, including European and non-European ancestry individuals. Genetic predisposition was measured using polygenic scores for 19 common diseases. Socioeconomic status was assessed through education and occupation. We evaluated associations of genetic and socioeconomic factors with disease risk and whether genetic associations differed across education levels. Models including both genetic and educational factors were compared with models including only one factor and models including their interaction. Results: Here, we show that both genetic predisposition and socioeconomic status are associated with disease risk across most conditions. For seven diseases, genetic associations are stronger in highly educated groups, while occupation shows smaller differences. Patterns are generally consistent across ancestry groups, though education associations are less stable in non-European individuals. While both education and polygenic scores independently improved prediction, combining both provided additional modest improvement to prediction for 16 and 12 out of 19 diseases in FinnGen and the UK Biobank, respectively. Conclusions: Genetic variation and social circumstances are linked to differences in disease risk both independently, and in combination with one another. Considering both factors modestly improves identification of higher-risk groups and highlights the value of accounting for social context alongside inherited variation in population-level assessments.
- 11 June 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Open AccessAssociation and risk prediction of 19 complex diseases with polygenic scores and socioeconomic status
Background: Differences in disease risk are linked to inherited genetic variation and social circumstances, but how these factors jointly relate to multiple diseases is not fully understood. This study investigates the independent and combined associations of genetic predisposition and socioeconomic status with common diseases. Methods: We analyzed data from 743,194 adults from three biobank studies in Finland and the United Kingdom, including European and non-European ancestry individuals. Genetic predisposition was measured using polygenic scores for 19 common diseases. Socioeconomic status was assessed through education and occupation. We evaluated associations of genetic and socioeconomic factors with disease risk and whether genetic associations differed across education levels. Models including both genetic and educational factors were compared with models including only one factor and models including their interaction. Results: Here, we show that both genetic predisposition and socioeconomic status are associated with disease risk across most conditions. For seven diseases, genetic associations are stronger in highly educated groups, while occupation shows smaller differences. Patterns are generally consistent across ancestry groups, though education associations are less stable in non-European individuals. While both education and polygenic scores independently improved prediction, combining both provided additional modest improvement to prediction for 16 and 12 out of 19 diseases in FinnGen and the UK Biobank, respectively. Conclusions: Genetic variation and social circumstances are linked to differences in disease risk both independently, and in combination with one another. Considering both factors modestly improves identification of higher-risk groups and highlights the value of accounting for social context alongside inherited variation in population-level assessments.
- Open Access
- 11 June 2026
- Published by Elsevier in Ophthalmology
- Vol. 133 (11) , 1308-1317
Polygenic Risk Impacts Lifetime Risk and Prognosis of Glaucoma
- 11 June 2026
- Published by Elsevier in Ophthalmology
- Vol. 133 (11) , 1308-1317
Open AccessPolygenic Risk Impacts Lifetime Risk and Prognosis of Glaucoma
- Open Access
Genetic architecture of 67 oral diseases and their links to systemic diseases
Oral and craniofacial diseases are common, yet their genetic basis and links to systemic health are incompletely understood. We performed genome-wide association analyses of 67 oral phenotypes in 500,348 FinnGen participants, identifying 105 genome-wide significant loci, including 47 previously unreported associations. Fine-mapping revealed 14 coding variants, such as a missense variant in USP31 for caries and in MANBA for oral leukoplakia, and a stop-gained variant in GPNMB for temporomandibular disorders. HLA analyses implicated DQA1 and DQB1 alleles in lichen planus and other mucosal disorders. We observed 378 statistically significant genetic correlations among oral traits, such as tooth loss and chronic apical periodontitis ( r g = 0.91, 95% CI [0.76 – 1.05], P = 1.73 × 10 -34 ), and 419 significant correlations between oral and systemic diseases, including periodontal diseases with chronic laryngitis (r g = 0.97, CI [0.58 – 1.36], P = 1.23 × 10 -6 ) and bruxism with gastro-oesophageal reflux (r g = 0.51, CI [0.38 – 0.65], P = 1.10 × 10 -13 ). These results expand the catalog of oral disease loci, uncover Finnish-enriched risk alleles, and highlight shared inflammatory, immune, and structural pathways connecting oral and systemic health.
Open AccessGenetic architecture of 67 oral diseases and their links to systemic diseases
Oral and craniofacial diseases are common, yet their genetic basis and links to systemic health are incompletely understood. We performed genome-wide association analyses of 67 oral phenotypes in 500,348 FinnGen participants, identifying 105 genome-wide significant loci, including 47 previously unreported associations. Fine-mapping revealed 14 coding variants, such as a missense variant in USP31 for caries and in MANBA for oral leukoplakia, and a stop-gained variant in GPNMB for temporomandibular disorders. HLA analyses implicated DQA1 and DQB1 alleles in lichen planus and other mucosal disorders. We observed 378 statistically significant genetic correlations among oral traits, such as tooth loss and chronic apical periodontitis ( r g = 0.91, 95% CI [0.76 – 1.05], P = 1.73 × 10 -34 ), and 419 significant correlations between oral and systemic diseases, including periodontal diseases with chronic laryngitis (r g = 0.97, CI [0.58 – 1.36], P = 1.23 × 10 -6 ) and bruxism with gastro-oesophageal reflux (r g = 0.51, CI [0.38 – 0.65], P = 1.10 × 10 -13 ). These results expand the catalog of oral disease loci, uncover Finnish-enriched risk alleles, and highlight shared inflammatory, immune, and structural pathways connecting oral and systemic health.
- Open Access
- 30 September 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (10) , 2418-2426
Limited overlap between genetic effects on disease susceptibility and disease survival
Understanding disease progression is of high biological and clinical interest. Unlike disease susceptibility, whose genetic basis has been abundantly studied, less is known about the genetics of disease progression and its overlap with disease susceptibility. Considering nine common diseases (n cases ranging from 11,980 to 124,682) across seven biobanks, we systematically compared genetic architectures of susceptibility and progression, defined as disease-specific mortality. We identified only one locus substantially associated with disease-specific mortality and showed that, at a similar sample size, more genome-wide significant loci can be identified in a genome-wide association study of disease susceptibility. Variants substantially affecting disease susceptibility were weakly or not associated with disease-specific mortality. Moreover, susceptibility polygenic scores (PGSs) were weak predictors of disease-specific mortality, while a PGS for general lifespan was substantially associated with disease-specific mortality for seven of nine diseases. We explored alternative definitions of disease progression and found that genetic signals for macrovascular complications in type 2 diabetes overlap with similar phenotypes in the general population; however, these effects are attenuated. Overall, our findings indicate limited similarity in genetic effects between disease susceptibility and disease-specific mortality, suggesting that larger sample sizes, different measures of progression, or the integration of related phenotypes from the general population is needed to identify the genetic underpinnings of disease progression.
- 30 September 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (10) , 2418-2426
Open AccessLimited overlap between genetic effects on disease susceptibility and disease survival
Understanding disease progression is of high biological and clinical interest. Unlike disease susceptibility, whose genetic basis has been abundantly studied, less is known about the genetics of disease progression and its overlap with disease susceptibility. Considering nine common diseases (n cases ranging from 11,980 to 124,682) across seven biobanks, we systematically compared genetic architectures of susceptibility and progression, defined as disease-specific mortality. We identified only one locus substantially associated with disease-specific mortality and showed that, at a similar sample size, more genome-wide significant loci can be identified in a genome-wide association study of disease susceptibility. Variants substantially affecting disease susceptibility were weakly or not associated with disease-specific mortality. Moreover, susceptibility polygenic scores (PGSs) were weak predictors of disease-specific mortality, while a PGS for general lifespan was substantially associated with disease-specific mortality for seven of nine diseases. We explored alternative definitions of disease progression and found that genetic signals for macrovascular complications in type 2 diabetes overlap with similar phenotypes in the general population; however, these effects are attenuated. Overall, our findings indicate limited similarity in genetic effects between disease susceptibility and disease-specific mortality, suggesting that larger sample sizes, different measures of progression, or the integration of related phenotypes from the general population is needed to identify the genetic underpinnings of disease progression.
- Open Access
The impact of polygenic score and socioeconomic status in predicting risk for 19 complex diseases
Both socioeconomic circumstances and genetic predisposition shape disease risk, yet their joint contribution across diseases has not been systematically examined. We studied 19 high-burden diseases in 743,194 participants (729,928 European; 13,266 non-European ancestry) from FinnGen, the UK Biobank, and Generation Scotland. Higher educational attainment was associated with lower risk of most conditions, but with higher risk of most common cancers. These associations were largely independent of disease-specific polygenic scores (PGSs). For seven out of 19 diseases, PGSs showed stronger effects among individuals with high education. Joint inclusion of education and PGSs modestly improved prediction for 14 and 10 out of 19 diseases in FinnGen and the UK Biobank, respectively. PGS associations were consistent across ancestries, whereas education effects were less stable; results using an alternative socioeconomic measure were directionally similar but smaller. Our findings highlight the distinct and partly interacting contributions of socioeconomic and genetic factors to disease risk.
Open AccessThe impact of polygenic score and socioeconomic status in predicting risk for 19 complex diseases
Both socioeconomic circumstances and genetic predisposition shape disease risk, yet their joint contribution across diseases has not been systematically examined. We studied 19 high-burden diseases in 743,194 participants (729,928 European; 13,266 non-European ancestry) from FinnGen, the UK Biobank, and Generation Scotland. Higher educational attainment was associated with lower risk of most conditions, but with higher risk of most common cancers. These associations were largely independent of disease-specific polygenic scores (PGSs). For seven out of 19 diseases, PGSs showed stronger effects among individuals with high education. Joint inclusion of education and PGSs modestly improved prediction for 14 and 10 out of 19 diseases in FinnGen and the UK Biobank, respectively. PGS associations were consistent across ancestries, whereas education effects were less stable; results using an alternative socioeconomic measure were directionally similar but smaller. Our findings highlight the distinct and partly interacting contributions of socioeconomic and genetic factors to disease risk.
- Open Access
- 8 September 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Chat-Based Digital Clinic Encourages Individuals at High Risk of Cardiovascular Disease to Contact Physician Following Digital Risk Communication (Preprint)
BACKGROUND Digital communication of cardiovascular disease (CVD) risk directly to individuals can promote preventive actions. We have previously shown that communicating CVD-risk, including polygenic risk information through a web portal leads to about 20 % of individuals at high risk of CVD contacting a physician. OBJECTIVE To test if mobile-optimised risk communication combined with a chat-based digital clinic for consulting a physician would increase preventive actions among individuals at high risk of CVD. METHODS We studied N=4808 Finnish individuals, aged 40-60 years with no history of cardiovascular disease and at least one major risk factor for CVD. The digital clinic group (N=1050) received the intervention. Matched controls (N=3758) were sampled from our previous study, and they received CVD-risk information without chat-based access to health professionals. RESULTS Compared to the matched controls, individuals in the digital clinic group were more likely to seek contact with a physician following digital risk communication (36.4 % vs. 18.6 % of individuals at high risk sought contact; P=.03). Majority of participants found the risk communication and chat-based digital consultation easy to understand (95 %) and useful (93 %). CONCLUSIONS Mobile-optimised CVD-risk communication followed by an easy access to physician’s consultation considerably elevated the likelihood of contacting physician compared to only communicating the individual’s risk. Further research is needed to target the health care resources optimally in this mobile setting to the individuals most in need for risk-lowering actions.
- 8 September 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessChat-Based Digital Clinic Encourages Individuals at High Risk of Cardiovascular Disease to Contact Physician Following Digital Risk Communication (Preprint)
BACKGROUND Digital communication of cardiovascular disease (CVD) risk directly to individuals can promote preventive actions. We have previously shown that communicating CVD-risk, including polygenic risk information through a web portal leads to about 20 % of individuals at high risk of CVD contacting a physician. OBJECTIVE To test if mobile-optimised risk communication combined with a chat-based digital clinic for consulting a physician would increase preventive actions among individuals at high risk of CVD. METHODS We studied N=4808 Finnish individuals, aged 40-60 years with no history of cardiovascular disease and at least one major risk factor for CVD. The digital clinic group (N=1050) received the intervention. Matched controls (N=3758) were sampled from our previous study, and they received CVD-risk information without chat-based access to health professionals. RESULTS Compared to the matched controls, individuals in the digital clinic group were more likely to seek contact with a physician following digital risk communication (36.4 % vs. 18.6 % of individuals at high risk sought contact; P=.03). Majority of participants found the risk communication and chat-based digital consultation easy to understand (95 %) and useful (93 %). CONCLUSIONS Mobile-optimised CVD-risk communication followed by an easy access to physician’s consultation considerably elevated the likelihood of contacting physician compared to only communicating the individual’s risk. Further research is needed to target the health care resources optimally in this mobile setting to the individuals most in need for risk-lowering actions.
- Open Access
- 12 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk
Polygenic scores (PGSs) offer the ability to predict genetic risk for complex diseases across the life course; a key benefit over short-term prediction models. To produce risk estimates relevant to clinical and public health decision-making, it is important to account for varying effects due to age and sex. Here, we develop a novel framework to estimate country-, age-, and sex-specific estimates of cumulative incidence stratified by PGS for 18 high-burden diseases. We integrate PGS associations from seven studies in four countries (N = 1,197,129) with disease incidences from the Global Burden of Disease. PGS has a significant sex-specific effect for asthma, hip osteoarthritis, gout, coronary heart disease and type 2 diabetes (T2D), with all but T2D exhibiting a larger effect in men. PGS has a larger effect in younger individuals for 13 diseases, with effects decreasing linearly with age. We show for breast cancer that, relative to individuals in the bottom 20% of polygenic risk, the top 5% attain an absolute risk for screening eligibility 16.3 years earlier. Our framework increases the generalizability of results from biobank studies and the accuracy of absolute risk estimates by appropriately accounting for age- and sex-specific PGS effects. Our results highlight the potential of PGS as a screening tool which may assist in the early prevention of common diseases.
- 12 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessA unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk
Polygenic scores (PGSs) offer the ability to predict genetic risk for complex diseases across the life course; a key benefit over short-term prediction models. To produce risk estimates relevant to clinical and public health decision-making, it is important to account for varying effects due to age and sex. Here, we develop a novel framework to estimate country-, age-, and sex-specific estimates of cumulative incidence stratified by PGS for 18 high-burden diseases. We integrate PGS associations from seven studies in four countries (N = 1,197,129) with disease incidences from the Global Burden of Disease. PGS has a significant sex-specific effect for asthma, hip osteoarthritis, gout, coronary heart disease and type 2 diabetes (T2D), with all but T2D exhibiting a larger effect in men. PGS has a larger effect in younger individuals for 13 diseases, with effects decreasing linearly with age. We show for breast cancer that, relative to individuals in the bottom 20% of polygenic risk, the top 5% attain an absolute risk for screening eligibility 16.3 years earlier. Our framework increases the generalizability of results from biobank studies and the accuracy of absolute risk estimates by appropriately accounting for age- and sex-specific PGS effects. Our results highlight the potential of PGS as a screening tool which may assist in the early prevention of common diseases.
- Open Access
- 20 March 2024
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 63 (10) , 2701-2710
Patterns of reproductive health in inflammatory rheumatic diseases and other immune-mediated diseases: a nationwide registry study
Objectives: Rheumatic diseases may impair reproductive success and pregnancy outcomes, but systematic evaluations across diseases are lacking. We conducted a nationwide cohort study to examine the impact of rheumatic diseases on reproductive health measures, comparing the impacts with those of other immune-mediated diseases (IMDs). Methods: Out of all of the 5 339 804 Finnish citizens, individuals born 1964–1984 and diagnosed with any of the 19 IMDs before age 30 (women) or 35 (men) were matched with 20 controls by birth year, sex, and education. We used data from nationwide health registers to study the impact of IMDs on reproductive health measures, such as reproductive success and, for women, ever having experienced adverse maternal and perinatal outcomes. Results: Several of the rheumatic diseases, particularly SLE, JIA, and seropositive RA, were associated with higher rates of childlessness and fewer children. The risks for pre-eclampsia, newborns being small for gestational age, preterm delivery, non-elective Caesarean sections, and need of neonatal intensive care were increased in many IMDs. Particularly, SLE, SS, type 1 diabetes, and Addison’s disease showed >2-fold risks for some of these outcomes. In most rheumatic diseases, moderate (1.1–1.5-fold) risk increases were observed for diverse adverse pregnancy outcomes, with similar effects in IBD, celiac disease, asthma, ITP, and psoriasis. Conclusion: Rheumatic diseases have a broad impact on reproductive health, with effects comparable with that of several other IMDs. Of the rheumatic diseases, SLE and SS conferred the largest risk increases on perinatal adverse event outcomes.
- 20 March 2024
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 63 (10) , 2701-2710
Open AccessPatterns of reproductive health in inflammatory rheumatic diseases and other immune-mediated diseases: a nationwide registry study
Objectives: Rheumatic diseases may impair reproductive success and pregnancy outcomes, but systematic evaluations across diseases are lacking. We conducted a nationwide cohort study to examine the impact of rheumatic diseases on reproductive health measures, comparing the impacts with those of other immune-mediated diseases (IMDs). Methods: Out of all of the 5 339 804 Finnish citizens, individuals born 1964–1984 and diagnosed with any of the 19 IMDs before age 30 (women) or 35 (men) were matched with 20 controls by birth year, sex, and education. We used data from nationwide health registers to study the impact of IMDs on reproductive health measures, such as reproductive success and, for women, ever having experienced adverse maternal and perinatal outcomes. Results: Several of the rheumatic diseases, particularly SLE, JIA, and seropositive RA, were associated with higher rates of childlessness and fewer children. The risks for pre-eclampsia, newborns being small for gestational age, preterm delivery, non-elective Caesarean sections, and need of neonatal intensive care were increased in many IMDs. Particularly, SLE, SS, type 1 diabetes, and Addison’s disease showed >2-fold risks for some of these outcomes. In most rheumatic diseases, moderate (1.1–1.5-fold) risk increases were observed for diverse adverse pregnancy outcomes, with similar effects in IBD, celiac disease, asthma, ITP, and psoriasis. Conclusion: Rheumatic diseases have a broad impact on reproductive health, with effects comparable with that of several other IMDs. Of the rheumatic diseases, SLE and SS conferred the largest risk increases on perinatal adverse event outcomes.
- Open Access
- 3 January 2024
- Published by Springer Nature in British Journal of Cancer
- Vol. 130 (4) , 651-659
Genome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening
Background: Hereditary factors, including single genetic variants and family history, can be used for targeting colorectal cancer (CRC) screening, but limited data exist on the impact of polygenic risk scores (PRS) on risk-based CRC screening. Methods: Using longitudinal health and genomics data on 453,733 Finnish individuals including 8801 CRC cases, we estimated the impact of a genome-wide CRC PRS on CRC screening initiation age through population-calibrated incidence estimation over the life course in men and women. Results: Compared to the cumulative incidence of CRC at age 60 in Finland (the current age for starting screening in Finland), a comparable cumulative incidence was reached 5 and 11 years earlier in persons with high PRS (80–99% and >99%, respectively), while those with a low PRS (< 20%) reached comparable incidence 7 years later. The PRS was associated with increased risk of post-colonoscopy CRC after negative colonoscopy (hazard ratio 1.76 per PRS SD, 95% CI 1.54–2.01). Moreover, the PRS predicted colorectal adenoma incidence and improved incident CRC risk prediction over non-genetic risk factors. Conclusions: Our findings demonstrate that a CRC PRS can be used for risk stratification of CRC, with further research needed to optimally integrate the PRS into risk-based screening.
- 3 January 2024
- Published by Springer Nature in British Journal of Cancer
- Vol. 130 (4) , 651-659
Open AccessGenome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening
Background: Hereditary factors, including single genetic variants and family history, can be used for targeting colorectal cancer (CRC) screening, but limited data exist on the impact of polygenic risk scores (PRS) on risk-based CRC screening. Methods: Using longitudinal health and genomics data on 453,733 Finnish individuals including 8801 CRC cases, we estimated the impact of a genome-wide CRC PRS on CRC screening initiation age through population-calibrated incidence estimation over the life course in men and women. Results: Compared to the cumulative incidence of CRC at age 60 in Finland (the current age for starting screening in Finland), a comparable cumulative incidence was reached 5 and 11 years earlier in persons with high PRS (80–99% and >99%, respectively), while those with a low PRS (< 20%) reached comparable incidence 7 years later. The PRS was associated with increased risk of post-colonoscopy CRC after negative colonoscopy (hazard ratio 1.76 per PRS SD, 95% CI 1.54–2.01). Moreover, the PRS predicted colorectal adenoma incidence and improved incident CRC risk prediction over non-genetic risk factors. Conclusions: Our findings demonstrate that a CRC PRS can be used for risk stratification of CRC, with further research needed to optimally integrate the PRS into risk-based screening.